Stella Diagnostics Inc. (SLDX)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -11.42 Million USD | -366.48% |
| 2022 | -2.44 Million USD | 48.32% |
| 2021 | -4.74 Million USD | -2775.35% |
| 2020 | -164.85 Thousand USD | 79.88% |
| 2019 | -819.46 Thousand USD | -11.07% |
| 2018 | -737.8 Thousand USD | -13588.31% |
| 2017 | -5390.00 USD | 0.0% |
| 2015 | -44.01 Thousand USD | 77.63% |
| 2014 | -196.73 Thousand USD | -76454.0% |
| 2013 | -256.98 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -192.3 Thousand USD | 11.83% |
| 2024 Q1 | -218.1 Thousand USD | 85.42% |
| 2023 Q4 | -1.49 Million USD | -200.77% |
| 2023 FY | -11.42 Million USD | -366.48% |
| 2023 Q1 | -9.33 Million USD | -1045.52% |
| 2023 Q2 | -204.37 Thousand USD | 97.81% |
| 2023 Q3 | -497.17 Thousand USD | -143.27% |
| 2022 Q2 | -370.73 Thousand USD | 60.69% |
| 2022 FY | -2.44 Million USD | 48.32% |
| 2022 Q4 | -814.65 Thousand USD | -25.0% |
| 2022 Q3 | -651.73 Thousand USD | -75.8% |
| 2022 Q1 | -942.99 Thousand USD | 0.0% |
| 2021 Q2 | -440.64 Thousand USD | 0.0% |
| 2021 Q3 | -185.84 Thousand USD | 57.82% |
| 2021 FY | -4.74 Million USD | -2775.35% |
| 2020 Q3 | -43.32 Thousand USD | 94.51% |
| 2020 FY | -164.85 Thousand USD | 79.88% |
| 2020 Q1 | -3090.00 USD | 0.0% |
| 2020 Q2 | -788.51 Thousand USD | -25418.12% |
| 2019 FY | -819.46 Thousand USD | -11.07% |
| 2018 FY | -737.8 Thousand USD | -13588.31% |
| 2018 Q1 | -220.15 Thousand USD | 0.0% |
| 2017 FY | -5390.00 USD | 0.0% |
| 2015 FY | -44.01 Thousand USD | 77.63% |
| 2014 FY | -196.73 Thousand USD | -76454.0% |
| 2013 FY | -256.98 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -820.044% |
| Arrayit Corporation | -3.62 Million USD | -215.442% |
| Atlantic International Corp. | -5.73 Million USD | -99.336% |
| Biocept, Inc. | -31.98 Million USD | 64.272% |
| Bioqual, Inc. | -19.63 Thousand USD | -58087.952% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -1379.903% |
| DermTech, Inc. | -103.73 Million USD | 88.985% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.459% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 45.141% |
| iMD Companies, Inc. | -175.44 Thousand USD | -6413.087% |
| IDenta Corp. | -1499.00 USD | -762204.87% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 507.523% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 29634.634% |
| InVitro International | -25.33 Thousand USD | -44996.294% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | -60.446% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -19563.667% |
| Medical Imaging Corp. | -819.48 Thousand USD | -1294.415% |
| NovelStem International Corp. | -3.52 Million USD | -224.095% |
| Optigenex Inc. | 1.39 Million USD | 921.589% |
| PharmChem, Inc. | 973.14 Thousand USD | 1274.227% |
| Proteome Sciences plc | -1.62 Million USD | -604.932% |
| Response Genetics, Inc | -21.37 Million USD | 46.546% |
| Rennova Health, Inc. | -1.4 Million USD | -710.69% |
| RushNet, Inc. | -684.7 Thousand USD | -1568.887% |
| ScreenPro Security Inc. | -2.59 Million USD | -340.782% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | -47.506% |
| Todos Medical Ltd. | -9.74 Million USD | -17.224% |